Company Filing History:
Years Active: 2019-2021
Title: The Innovative Contributions of Robert Rosenberg
Introduction
Robert Rosenberg is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer treatment, particularly through his innovative methods for predicting and treating colorectal cancer. With a total of 2 patents, his work has the potential to impact the lives of many patients.
Latest Patents
Rosenberg's latest patents focus on methods for treating colorectal cancer using prognostic genetic markers. This invention relates to prognostic signatures, compositions, and methods for determining the prognosis of cancer in a patient, specifically for colorectal cancer. The invention utilizes genetic markers to predict the prognosis of cancer, allowing for tailored treatment approaches. It includes methods for predicting the likelihood of long-term survival of a cancer patient, determining treatment regimes, and preparing treatment modalities, along with kits and devices for implementing these methods.
Career Highlights
Throughout his career, Robert Rosenberg has worked with various companies, including Pacific Edge Limited and Pacific Edge Biotechnology Limited. His experience in these organizations has contributed to his expertise in the field of cancer research and treatment.
Collaborations
Rosenberg has collaborated with notable individuals such as Hjalmar Nekarda and Jan Friederichs. These partnerships have likely enhanced his research and development efforts in the medical field.
Conclusion
Robert Rosenberg's innovative work in cancer treatment exemplifies the importance of research and development in improving patient outcomes. His contributions through patents and collaborations highlight his commitment to advancing medical science.